These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20626464)

  • 1. Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra-lesional injections of anti-amyloid antibodies.
    Clos AL; Lasagna-Reeves CA; Wagner R; Kelly B; Jackson GR; Kayed R
    Exp Dermatol; 2010 Oct; 19(10):904-11. PubMed ID: 20626464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunofluorescent staining properties of amyloid substance in primary localized cutaneous amyloidosis using anti-keratin antibody].
    Yoneda K; Kitajima Y; Yanagihara M; Mori S
    Nihon Hifuka Gakkai Zasshi; 1984 Feb; 94(2):151-5. PubMed ID: 6204080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cutaneous amyloidoses].
    Ruzicka T; Donhauser G; Linke RP; Landthaler M; Bieber T
    Hautarzt; 1990 May; 41(5):245-55. PubMed ID: 2197250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression in lichen amyloidosus and macular amyloidosis.
    Apaydin R; Gürbüz Y; Bayramgürler D; Müezzinoglu B; Bilen N
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):305-9. PubMed ID: 15096140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid in localized cutaneous amyloidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis.
    Masu S; Hosokawa M; Seiji M
    Acta Derm Venereol; 1981; 61(5):381-4. PubMed ID: 6172924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated nodular primary localized cutaneous amyloidosis].
    Feito-Rodríguez M; García-Macarrón J; Pagán-Muñoz B; Mariño-Enríquez A; Vidaurrázaga-Díaz Y Arcaya C; Díaz-Díaz RM; Casado-Jiménez M
    Actas Dermosifiliogr; 2008 Oct; 99(8):648-52. PubMed ID: 19080897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cutaneous amyloid employing anti-keratin antibodies and the immunoperoxidase technique (PAP method).
    Ishii M; Asai Y; Hamada T
    Acta Derm Venereol; 1984; 64(4):281-5. PubMed ID: 6209883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary localized cutaneous amyloidosis--lichen amyloidosus. A case report.
    Gałazka K; Bogdaszewska-Czabanowska J; Setkowicz M; Stachura J
    Pol J Pathol; 1999; 50(2):119-22. PubMed ID: 10481537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of cytokeratin profiles in localized cutaneous amyloids.
    Chang YT; Liu HN; Wang WJ; Lee DD; Tsai SF
    Arch Dermatol Res; 2004 Jul; 296(2):83-8. PubMed ID: 15141317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
    Hoshii Y; Kawano H; Cui D; Takeda T; Gondo T; Takahashi M; Kogishi K; Higuchi K; Ishihara T
    Am J Pathol; 1997 Oct; 151(4):911-7. PubMed ID: 9327723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental murine amyloidosis: a model system for studying amyloid formation.
    Baumal R; Wilson B; Pass E
    Can Med Assoc J; 1975 Sep; 113(6):512-6. PubMed ID: 1080430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oligomers in the amyloidogenesis of primary cutaneous amyloidosis.
    Clos AL; Lasagna-Reeves CA; Kelly B; Wagner R; Wilkerson M; Jackson GR; Kayed R
    J Am Acad Dermatol; 2011 Nov; 65(5):1023-31. PubMed ID: 21669474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkali-degradation of amyloid: an ancient method useful for making monoclonal antibodies against amyloid fibril proteins.
    Westermark GT; Sletten K; Westermark P
    Scand J Immunol; 2009 Dec; 70(6):535-40. PubMed ID: 19906195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils.
    Kitajima Y; Seno J; Aoki S; Tada S; Yaoita H
    Arch Dermatol; 1986 Dec; 122(12):1425-30. PubMed ID: 3789778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
    J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucocutaneous manifestations of amyloidosis].
    Timmer-de Mik L; van der Waal RI; Canninga-van Dijk MR; Dikland WJ; Rodenburg CJ; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2007 Sep; 151(37):2032-8. PubMed ID: 17929711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescence and histochemical studies of localized cutaneous amyloidosis.
    Norén P; Westermark P; Cornwell GG; Murdoch W
    Br J Dermatol; 1983 Mar; 108(3):277-85. PubMed ID: 6187353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous amyloidosis of the external ear: a clinicopathological and immunohistochemical study of 17 cases.
    Wenson SF; Jessup CJ; Johnson MM; Cohen LM; Mahmoodi M
    J Cutan Pathol; 2012 Feb; 39(2):263-9. PubMed ID: 22077601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.